Search
for
Sort by
Research 931–960 of 1000+
- rwSALT: a regrowth-weighted SALT score providing direct pixel-level measurement rather than visual estimation
- rwSALT: a regrowth-weighted SALT score providing direct pixel-level measurement rather than visual estimation
- Treatment of longstanding alopecia areata universalis of the eyebrows/facial hair with oral and topical tofacitinib
- Hair loss is a symptom of many complex medical and psychological problems
- Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications
- Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications
- Effectiveness and safety of oral Janus kinase inhibitors in patients aged ≤12 with alopecia areata: a systematic review and meta-analysis
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- New Modalities in the Treatment of Refractory Alopecia Areata
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- “<i>Nomen Omen</i>: The Myth of God Janus”
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- What is behind the ‘swarm of bees’ in alopecia areata
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
- Folliculitis decalvans responsive to tofacitinib: A case series
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Alopecia Areata: Current and Emerging Therapies
- Supplementary Material for: TOFACITINIB IN OVERLAPPING AUTOIMMUNE AND AUTOINFLAMMATORY DISORDERS: A CASE REPORT OF A DUAL GRAHAM-LITTLE-PICCARDI-LASSEUR SYNDROME AND HIDRADENITIS SUPPURATIVA
- Supplementary Material for: TOFACITINIB IN OVERLAPPING AUTOIMMUNE AND AUTOINFLAMMATORY DISORDERS: A CASE REPORT OF A DUAL GRAHAM-LITTLE-PICCARDI-LASSEUR SYNDROME AND HIDRADENITIS SUPPURATIVA
- 0054 Treg-targeted therapies restrain disease in a murine model of alopecia areata
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- DataSheet2_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Nemolizumab Treatment for Severe Atopic Dermatitis Led to the Simultaneous Improvement of Coexisting Refractory Alopecia Areata: A Case Report